Search

Ni Ding Phones & Addresses

  • Union City, CA
  • South San Francisco, CA
  • San Mateo, CA
  • Redwood City, CA
  • Stockton, CA

Business Records

Name / Title
Company / Classification
Phones & Addresses
Ni Ding
M
Llh Investment Group, LLC
4103 Cortona Ct, San Jose, CA 95135
7220 Red Cinder St, Las Vegas, NV 89131

Publications

Us Patents

Methods For Polymeric Coatings Stents

View page
US Patent:
6673385, Jan 6, 2004
Filed:
Jun 28, 2001
Appl. No.:
09/893957
Inventors:
Ni Ding - San Jose CA
Deborra Sanders Millare - San Jose CA
Syed F. A. Hossainy - Fremont CA
Assignee:
Advanced Cardiovascular Systems, Inc. - Santa Clara CA
International Classification:
A61L 2700
US Classification:
427 228, 427 21, 427 224, 427 225, 427 23, 427508, 427487, 427421
Abstract:
This invention provides a method of forming a polymeric coating for a stent. The method can comprise applying a prepolymer or a combination of prepolymers to the stent and initiating polymerization to form a polymeric coating for the stent. The coating material can optionally contain a biologically active agent or combination of agents.

Polycationic Peptide Coatings And Methods Of Making The Same

View page
US Patent:
7011842, Mar 14, 2006
Filed:
Jun 21, 2002
Appl. No.:
10/177114
Inventors:
Murthy V Simhambhatla - San Jose CA, US
Ni Ding - San Jose CA, US
Stephen D. Pacetti - San Jose CA, US
Assignee:
Advanced Cardiovascular Systems, Inc. - Santa Clara CA
International Classification:
A61F 2/02
US Classification:
424426, 424486
Abstract:
Polycationic peptide coatings for implantable medical devices and methods of making the same are described. The methods include applying an emulsion on the device, the emulsion including a polymer and a polycationic peptide. Other methods include incorporation of the polycationic peptide in microspheres and liposomes.

Therapeutic Composition And A Method Of Coating Implantable Medical Devices

View page
US Patent:
7022334, Apr 4, 2006
Filed:
Mar 20, 2002
Appl. No.:
10/104179
Inventors:
Ni Ding - San Jose CA, US
Assignee:
Advanced Cardiovascular Systems, Inc. - Santa Clara CA
International Classification:
A61F 2/02
US Classification:
424423, 424424, 424425
Abstract:
A therapeutic composition is provided including a polysaccharide or a cationic peptide dissolved in an organic substance. The polysaccharide can be heparin or a derivative of heparin. The cationic peptide can be L-arginine, oligo-L-arginine or poly-L-arginine. The organic substance can be formamide. A method of coating an implantable medical device is also provided, comprising applying the therapeutic composition to the device and allowing the organic substance to evaporate. The device can be a stent.

Polycationic Peptide Coatings And Methods Of Coating Implantable Medical Devices

View page
US Patent:
7033602, Apr 25, 2006
Filed:
Jun 21, 2002
Appl. No.:
10/177116
Inventors:
Stephen D. Pacetti - San Jose CA, US
Eugene T Michal - San Francisco CA, US
Syed F A Hossainy - Fremont CA, US
Ni Ding - San Jose CA, US
Wouter E Roorda - Palo Alto CA, US
Assignee:
Advanced Cardiovascular Systems, Inc. - Santa Clara CA
International Classification:
A61F 2/02
US Classification:
424426
Abstract:
Coatings for medical devices which include polycationic peptides such as L-arginine and methods for fabricating the coatings are disclosed.

Rate Limiting Barriers For Implantable Devices And Methods For Fabrication Thereof

View page
US Patent:
7175873, Feb 13, 2007
Filed:
Jul 18, 2002
Appl. No.:
10/198898
Inventors:
Wouter E. Roorda - Palo Alto CA, US
Syed F. A. Hossainy - Fremont CA, US
Ni Ding - San Jose CA, US
Fuh-Wei Tang - Temecula CA, US
Stephen D. Pacetti - San Jose CA, US
Assignee:
Advanced Cardiovascular Systems, Inc. - Santa Clara CA
International Classification:
A61L 33/10
US Classification:
427 214, 427 225
Abstract:
A method of coating an implantable medical device, such as a stent, is disclosed. The method includes applying a formulation on a first polymer layer containing a therapeutic substance to form a second layer. The formulation can contain a highly hydrophobic polymer or a solvent which is a poor solvent for the drug or the polymer of the first layer. The formulation can have a low surface tension value or a high Weber number value.

Stent Coatings Containing Self-Assembled Monolayers

View page
US Patent:
7232573, Jun 19, 2007
Filed:
Sep 26, 2002
Appl. No.:
10/255911
Inventors:
Ni Ding - San Jose CA, US
Assignee:
Advanced Cardiovascular Systems, Inc. - Santa Clara CA
International Classification:
A61F 2/00
US Classification:
424423
Abstract:
A coating for a medical device, particularly for a drug eluting stent, is described. The coating includes a self-assembled monolayer.

Polyacrylates Coatings For Implantable Medical Devices

View page
US Patent:
7247313, Jul 24, 2007
Filed:
Jun 21, 2002
Appl. No.:
10/176504
Inventors:
Wouter E. Roorda - Palo Alto CA, US
Ni Ding - San Jose CA, US
Stephen D. Pacetti - San Jose CA, US
Eugene T. Michal - San Francisco CA, US
Ashok A. Shah - San Jose CA, US
Syed F. A. Hossainy - Fremont CA, US
Assignee:
Advanced Cardiovascular Systems, Inc. - Santa Clara CA
International Classification:
A61F 2/02
A61K 9/00
US Classification:
424423, 424426, 424400
Abstract:
A coating for a medical device, particularly for a drug eluting stent, is described. The coating can include a polyacrylate, a blend of polyacrylates, or a blend of the polyacrylate with other polymers, for example, poly(ethylene-co-vinyl alcohol).

Fluid Treatment Of A Polymeric Coating On An Implantable Medical Device

View page
US Patent:
7285304, Oct 23, 2007
Filed:
Jun 25, 2003
Appl. No.:
10/603889
Inventors:
Syed F. A. Hossainy - Fremont CA, US
Ni Ding - San Jose CA, US
Stephen D. Pacetti - San Jose CA, US
Assignee:
Advanced Cardiovascular Systems, Inc. - Santa Clara CA
International Classification:
A61L 33/00
US Classification:
427 224, 427 225, 427 227
Abstract:
A method of manufacturing an implantable medical device including applying a composition to an implantable medical device, the composition including a polymer, an active agent and a solvent; allowing the solvent to evaporate to form a dry coating, the dry coating comprising less than about 2% residual fluid content (w/w); applying a fluid to the dry coating, the fluid being substantially free from any polymer; and allowing the fluid to evaporate from the coating.
Ni Ding from Union City, CA, age ~32 Get Report